{
  "retracted": false,
  "timestamp": 1508889600000,
  "updates": [
    {
      "timestamp": 1550506546468,
      "identifier": {
        "doi": "10.1007/s10549-017-4539-3"
      },
      "type": "correction"
    }
  ],
  "identifier": {
    "doi": "10.1007/s10549-017-4328-z"
  },
  "journal": "Breast Cancer Research and Treatment",
  "publisher": "Springer Nature",
  "title": "Correction to: IRIS study: a phase II study of the steroid sulfatase inhibitor Irosustat when added to an aromatase inhibitor in ER-positive breast cancer patients"
}
